Clinical data | |
---|---|
Routes of administration |
Oral |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
|
|
Synonyms | 3β-Hydroxynorethisterone 3,17-diacetate |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
ECHA InfoCard | 100.005.496 |
Chemical and physical data | |
Formula | C24H32O4 |
Molar mass | 384.509 g/mol |
3D model (Jmol) | |
|
|
|
Etynodiol diacetate (sold as Continuin, Femulen, Luteonorm, Luto-Metrodiol, and Metrodiol), or ethynodiol diacetate (USAN, BAN, JAN), also known as norethindrol diacetate or 3β-hydroxynorethisterone diacetate, is a steroidal progestin of the 19-nortestosterone group which is used as a hormonal contraceptive. It is the 3β,17β-diacetate ester of etynodiol, and acts as a rapidly converted prodrug to norethisterone, with etynodiol occurring as an intermediate. Etynodiol diacetate has weak androgenic activity, and, unlike most progestins but similarly to norethisterone and noretynodrel, also has some estrogenic activity.
Etynodiol diacetate is virtually inactive in terms of affinity for the progesterone and androgen receptors and acts as a prodrug of etynodiol, which in turn is a prodrug of norethisterone. Upon oral administration and during first-pass metabolism in the liver, etynodiol diacetate is rapidly converted by esterases into etynodiol, which is followed by oxygenation of the C3 hydroxyl group to produce norethisterone.